Stocktoria
Avalo Therapeutics, Inc. AVTX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-11-13
Avalo Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 2,387,026 | $44.1M | 12.89% |
| CITADEL ADVISORS LLC | 450,233 | $8.3M | 2.43% |
| RENAISSANCE TECHNOLOGIES LLC | 357,200 | $6.6M | 1.93% |
| TWO SIGMA INVESTMENTS, LP | 67,094 | $1.2M | 0.36% |
| BlackRock Finance, Inc. | 329 | $4,103 | — |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.